GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...

Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding and treatment of the fatal neurodegenerative ...

The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount a strong immune response to one strain, leaving them ...

New research from scientists at the University of Washington (UW) School of Medicine and Duke University describes how cellular RNA helps regulate antiviral signaling as part of the immune ...

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice that outlines new discoveries about the roles of calcium signaling, regulatory ...

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of NG-350A, a new gene therapy based on its proprietary tumor ...

Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business unit, established a U.S ...

Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its proximity to critical brain ...